Search Results - "PELLEGRINI, Cristina"
-
1
Understanding the Molecular Genetics of Basal Cell Carcinoma
Published in International journal of molecular sciences (22-11-2017)“…Basal cell carcinoma (BCC) is the most common human cancer and represents a growing public health care problem. Several tumor suppressor genes and…”
Get full text
Journal Article -
2
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
Published in Nature genetics (01-05-2014)“…Maria Teresa Landi and colleagues identify a rare missense variant in POT1 shared by five melanoma-prone families from Italy and associated with increased…”
Get full text
Journal Article -
3
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments
Published in PloS one (22-08-2017)“…Several immune-related markers have been implicated in basal cell carcinoma (BCC) pathogenesis. The BCC inflammatory infiltrate is dominated by Th2 cytokines,…”
Get full text
Journal Article -
4
Molecular alterations in basal cell carcinoma subtypes
Published in Scientific reports (24-06-2021)“…A number of genes have been implicated in the pathogenesis of BCC in addition to the Hedgehog pathway, which is known to drive the initiation of this tumour…”
Get full text
Journal Article -
5
The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions
Published in PLoS biology (29-04-2024)“…Muscarinic acetylcholine receptors are prototypical G protein-coupled receptors (GPCRs), members of a large family of 7 transmembrane receptors mediating a…”
Get full text
Journal Article -
6
Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum
Published in Frontiers in immunology (13-07-2023)“…The idea of psoriatic disease continuum has been progressively prompted based on the advances of the knowledge about the pathogenic steps underpinning the…”
Get full text
Journal Article -
7
Editorial: New tools and molecular advances in hyperproliferative skin disorders
Published in Frontiers in medicine (11-08-2022)Get full text
Journal Article -
8
Editorial: Molecular genetics of cutaneous melanoma: current status and future direction-volume II
Published in Frontiers in molecular biosciences (31-08-2023)Get full text
Journal Article -
9
Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma
Published in International journal of molecular sciences (16-03-2019)“…The role of telomere biology and telomerase activation in skin cancers has been investigated in melanoma and basal cell carcinoma but limited evidence is…”
Get full text
Journal Article -
10
Familial Melanoma: Diagnostic and Management Implications
Published in Dermatology practical & conceptual (01-01-2019)“…An estimated 5%-10% of all cutaneous melanoma cases occur in families. This review describes susceptibility genes currently known to be involved in melanoma…”
Get full text
Journal Article -
11
Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
Published in Dermatology practical & conceptual (01-09-2021)“…Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer affecting humans. The combination of the increasing incidence and high mortality in…”
Get full text
Journal Article -
12
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
Published in Scientific reports (14-05-2020)“…Basal cell carcinoma (BCC) represents the most commonly diagnosed human cancer among persons of European ancestry with etiology mainly attributed to…”
Get full text
Journal Article -
13
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
Published in Journal of experimental & clinical cancer research (18-06-2018)“…Oncogenes derived from the neurotrophin receptor tropomyosin-related kinase TrkA act as drivers in sub-populations of a wide-range of human cancers. This,…”
Get full text
Journal Article -
14
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy
Published in Melanoma research (01-06-2017)“…Genetic susceptibility to cutaneous melanoma has been investigated in Italian high-risk melanoma patients from different geographical regions. CDKN2A, CDK4,…”
Get full text
Journal Article -
15
Photodynamic Therapy for the Treatment of Bowen's Disease: A Review on Efficacy, Non-Invasive Treatment Monitoring, Tolerability, and Cosmetic Outcome
Published in Biomedicines (01-04-2024)“…Bowen's disease represents the in situ form of cutaneous squamous cell carcinoma; although it has an excellent prognosis, 3-5% of lesions progress to invasive…”
Get full text
Journal Article -
16
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross‐sectional study
Published in Dermatologic therapy (01-05-2021)“…In psoriasis patients, satisfaction and patients' attitude toward treatment are heterogeneous depending on several factors and remain poorly investigated,…”
Get full text
Journal Article -
17
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases
Published in Acta dermato-venereologica (01-01-2020)“…Mutations in MAPK signalling genes are driver events in melanoma, and have therapeutic relevance in the metastatic and adjuvant setting. This study evaluated…”
Get full text
Journal Article -
18
Editorial: Molecular Genetics of Cutaneous Melanoma: Current Status and Future Direction
Published in Frontiers in molecular biosciences (22-12-2021)Get full text
Journal Article -
19
Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
Published in International journal of molecular sciences (09-11-2017)“…Pelvic Melanoma relapse occurs in 15% of patients with loco regional metastases, and 25% of cases do not respond to new target-therapy and/or immunotherapy…”
Get full text
Journal Article -
20
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma
Published in Cells (Basel, Switzerland) (05-01-2023)“…Post-therapeutic relapse, poor survival rates and increasing incidence justify the search for novel therapeutic targets and strategies in cutaneous malignant…”
Get full text
Journal Article